Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.2723
-0.0007 (-0.26%)
At close: Jan 22, 2026, 4:00 PM EST
0.2750
+0.0027 (0.99%)
Pre-market: Jan 23, 2026, 5:07 AM EST

Virax Biolabs Group Revenue

Virax Biolabs Group had revenue of $1.61K in the half year ending September 30, 2025, a decrease of -97.90%. This brings the company's revenue in the last twelve months to $2.99K, down -96.48% year-over-year. In the fiscal year ending March 31, 2025, Virax Biolabs Group had annual revenue of $6.33K, down -95.95%.

Revenue (ttm)
$2.99K
Revenue Growth
-96.48%
P/S Ratio
676.96
Revenue / Employee
$157
Employees
19
Market Cap
2.02M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20256.33K-150.09K-95.95%
Mar 31, 2024156.42K147.86K1,727.11%
Mar 31, 20238.56K--
Mar 31, 2022---
Mar 31, 2021123.82K23.94K23.97%
Mar 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition